Repare Therapeutics (RPTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist

3.470
+0.030+0.87%

Close Oct 1 16:00 ET

147.29MMarket Cap-2128P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Stifel Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $9
Moomoo NewsOct 1 07:31 ET · Ratings
Stifel Nicolaus Keeps Their Buy Rating on Repare Therapeutics (RPTX)
TipRanksOct 1 07:07 ET · Ratings
Morgan Stanley Maintains Repare Therapeutics(RPTX.US) With Hold Rating, Maintains Target Price $8
Moomoo NewsOct 1 06:35 ET · Ratings
Hold Rating on Repare Therapeutics Amidst Early Promising Clinical Results and Safety Concerns
TipRanksOct 1 05:46 ET · Ratings
Stocks to Watch: CVS Health, PepsiCo, Repare Therapeutics
WSJSep 30 19:37 ET
12 Health Care Stocks Moving In Monday's After-Market Session
BenzingaSep 30 16:31 ET

Comments

Stock_Drift

Yesterday 04:16

After Hours Ticks, 4:14pm, EST.

$Mill City Ventures III (MCVT.US)$ $Jowell Global (JWEL.US)$ $NCI (01336.HK)$ $Onconetix (ONCO.US)$ $YXT.COM Group Holding (YXT.US)$ $Cognition Therapeutics (CGTX.US)$ $Ambow Education (AMBO.US)$ $Matinas BioPharma (MTNB.US)$ $TCTM Kids IT Education (TCTM.US)$ $N2OFF (NITO.US)$ $Repare Therapeutics (RPTX.US)$ $ZK International (ZKIN.US)$
📊⚡️📊

Jaguar8

Yesterday 04:12

NEWS

$Repare Therapeutics (RPTX.US)$
Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting
Repare Therapeutics (Nasdaq: RPTX) presented Phase 1 data at the ASTRO Annual Meeting, showcasing the potential of camonsertib, an oral ATR inhibitor, combined with palliative radiation for treating metastatic tumors with ATM mutations.
The study enrolled 17 patients, 12 with pathogenic ATM mutations and 5 with va...

Stock_Drift

Sep 23 06:14

$Repare Therapeutics (RPTX.US)$

Stock_Drift

Sep 23 06:07

$Repare Therapeutics (RPTX.US)$

Jaguar8

Sep 23 06:06

NEWS

$Repare Therapeutics (RPTX.US)$
Repare Therapeutics Announces New Data Underscoring Need for Additional Treatment Solutions for Patients with Metastatic Gynecologic Cancers
Repare Therapeutics presented new data at AACR's Ovarian Cancer Research Symposium, highlighting the impact of FBXW7, PPP2R1A, and CCNE1 alterations in metastatic ovarian and endometrial cancers. The analysis of approximately 2,000 patients revealed:
1. Ovarian cancer: Patients with these biomarkers (Lunre BM+) had a media...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

RPTX Repare Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target